By analyzing clinical data of recruited HCC, higher METTL3 was detected in patients with lymphatic metastasis (Figure 2(a)), ≥5 cm of tumor size (Figure 2(b)), or stage III + IV (Figure 2(c)). The gene discussed is METTL3; the disease is neoplasm.